Currently our product pipeline consists of ten highly innovative projects in various stages of development, from early discovery to late clinical phases. Four of the projects include partners who are in the process of completing the clinical development, worldwide registration and eventual commercialization.

Palau's personnel expenses are partly financed by Fondo Social Europeo as well as the Ministerio de Ciencia e Innovación and the Subprograma Torres Quevedo